Journal article · 2025 · Open access

Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy

Christopher R. Bye, Elizabeth Ling Qian, Katherine Lim, Maciej Daniszewski, Fleur C. Garton, Bảo C. Trần-Lê, Helena Hai Liang, Tian Lin, John George Lock, Duncan E. Crombie, Steven Morgan, Yi Hu and 18 more

Nature Neuroscience, 29(1), 40–52 · Published 24 November 2025 · DOI 10.1038/s41593-025-02118-7

Open PDFView at the publisherCite this paper

In brief

“Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy” is a 2025 journal article by Christopher R. Bye and 29 co-authors, published in Nature Neuroscience. OpenAlex counts 33 citations as of 16 November 2026. It is open access under a CC BY licence: the full text is free to read at Nature Neuroscience.

Citations
33
Most cited in
2026 (32)
Field-weighted impact
14.35
References
76
Authors
30

Abstract

Heterogeneous and predominantly sporadic neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), remain highly challenging to model. Patient-derived induced pluripotent stem cell (iPSC) technologies offer great promise for these diseases; however, large-scale studies demonstrating accelerated neurodegeneration in patients with sporadic disease are limited. Here we generated an iPSC library from 100 patients with sporadic ALS (SALS) and conducted population-wide phenotypic screening. Motor neurons derived from patients with SALS recapitulated key aspects of the disease, including reduced survival, accelerated neurite degeneration correlating with donor survival, transcriptional dysregulation and pharmacological rescue by riluzole. Screening of drugs previously tested in ALS clinical trials revealed that 97% failed to mitigate neurodegeneration, reflecting trial outcomes and validating the SALS model. Combinatorial testing of effective drugs identified baricitinib, memantine and riluzole as a promising therapeutic combination for SALS. These findings demonstrate that patient-derived iPSC models can recapitulate sporadic disease features, paving the way for a new generation of disease modeling and therapeutic discovery in ALS.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bye, C. R., Qian, E. L., Lim, K., Daniszewski, M., Garton, F. C., Trần-Lê, B. C., Liang, H. H., Lin, T., Lock, J. G., Crombie, D. E., Morgan, S., Hu, Y., Barton, S. K., Palmer, L. M., Djouma, E., Kodikara, S., Cao, K. L., Dharmadasa, T., Henders, A. K., . . . Turner, B. J. (2025). Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy. Nature Neuroscience, 29(1), 40–52. https://doi.org/10.1038/s41593-025-02118-7

MLA 9

Bye, Christopher R., et al. “Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy.” Nature Neuroscience, vol. 29, no. 1, 2025, pp. 40–52. https://doi.org/10.1038/s41593-025-02118-7.

Chicago

Bye, Christopher R., Elizabeth Ling Qian, Katherine Lim, Maciej Daniszewski, Fleur C. Garton, Bảo C. Trần-Lê, Helena Hai Liang, et al. 2025. “Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy.” Nature Neuroscience 29 (1): 40–52. https://doi.org/10.1038/s41593-025-02118-7.

Harvard

Bye, C. R. et al. (2025) ‘Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy’, Nature Neuroscience, 29(1), pp. 40–52. doi:10.1038/s41593-025-02118-7.

IEEE

C. R. Bye et al., “Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy,” Nature Neuroscience, vol. 29, no. 1, pp. 40–52, 2025, doi: 10.1038/s41593-025-02118-7.

BibTeX

@article{bye2025large,
  title     = {{Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy}},
  author    = {Bye, Christopher R. and Qian, Elizabeth Ling and Lim, Katherine and Daniszewski, Maciej and Garton, Fleur C. and Trần-Lê, Bảo C. and Liang, Helena Hai and Lin, Tian and Lock, John George and Crombie, Duncan E. and Morgan, Steven and Hu, Yi and Barton, Samantha K. and Palmer, Lucy M. and Djouma, Elvan and Kodikara, Saritha and Cao, Kim‐Anh Lê and Dharmadasa, Thanuja and Henders, Anjali K. and Ziser, Laura and Kiernan, Matthew C. and Talbot, Kevin and Needham, Merrilee and Fletcher, Sue and Talman, Paul S. and Mathers, Susan and Wray, Naomi R. and Hewitt, Alex William and Pébay, Alice and Turner, Bradley J.},
  journal   = {Nature Neuroscience},
  year      = {2025},
  volume    = {29},
  number    = {1},
  pages     = {40--52},
  doi       = {10.1038/s41593-025-02118-7},
  url       = {https://doi.org/10.1038/s41593-025-02118-7}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research

  • sporadic ALS
  • induced pluripotent stem cells
  • motor neurons
  • iPSC-derived disease models
  • drug screening
  • combination therapy
  • baricitinib
  • memantine

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Bye, C. R., Qian, E. L., Lim, K., Daniszewski, M., Garton, F. C., Trần-Lê, B. C., Liang, H. H., Lin, T., Lock, J. G., Crombie, D. E., Morgan, S., Hu, Y., Barton, S. K., Palmer, L. M., Djouma, E., Kodikara, S., Cao, K. L., Dharmadasa, T., Henders, A. K., . . . Turner, B. J. (2025). Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy. Nature Neuroscience, 29(1), 40–52. https://doi.org/10.1038/s41593-025-02118-7

How many times has this paper been cited?

33 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Neuroscience: sign in and open the PDF from this page.

Who wrote this paper?

Christopher R. Bye, Elizabeth Ling Qian, Katherine Lim, Maciej Daniszewski, Fleur C. Garton, Bảo C. Trần-Lê, Helena Hai Liang, Tian Lin, John George Lock, Duncan E. Crombie, Steven Morgan, Yi Hu and 18 more.

What is the DOI of this paper?

10.1038/s41593-025-02118-7, permanently at https://doi.org/10.1038/s41593-025-02118-7. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.